We can’t show the full text here under this license. Use the link below to read it at the source.
Association of sleep quality and urinary melatonin levels with endometrial cancer: A case control pilot study
Links between sleep quality, melatonin levels, and risk of uterine cancer
AI simplified
Abstract
The mean melatonin level among women with endometrial cancer was 6.72 ± 2.71 ng/mL, significantly lower than the 12.38 ± 6.64 ng/mL in healthy controls.
- Women with endometrial cancer had a higher average score on the (8.77) compared to controls (6.27), indicating poorer sleep quality.
- Sleep onset latency was significantly longer in patients with endometrial cancer (P = 0.002).
- Sleep duration scores also differed significantly between cases and controls (P = 0.006).
- Alterations in sleep quality and low melatonin levels may be associated with an increased risk of endometrial carcinoma.
AI simplified
Key numbers
8.77
Increase in Score
global scores among endometrial carcinoma patients
6.72 ng/mL
Decrease in Urinary Melatonin Levels
Urinary melatonin levels among endometrial carcinoma patients